Syncom Formulation (India) Ltd.

BSE: 524470

Expensive Performer

Download real time

16.96 -0.08 (-0.47%)

39.30% Fall from 52W High

2.3M NSE+BSE Volume

BSE 28 Apr, 2025 4:01 PM (IST)

1,594.2

Market Cap

Above industry Median

1.2

Beta 1Year

Very High Volatility

Syncom Formulation (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Syncom Formulation (India) Ltd. on BSE

Load latest

Syncom Formulation (India) Ltd.

12 Aug 2024

16.96

-0.47%

Result

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Regulation 33(3) Of SEBI (LODR) Regulations, 2015- Submission Of …

BSE India

Submission of Unaudited Standalone and Consolidated financial Results for the quarter ended 30.06.2024

Syncom Formulation (India) Ltd.

02 Aug 2024

16.96

-0.47%

Board Meeting

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of …

BSE India

SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 as amended from time to time, we are pleased to inform that 2/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 12th day of August, 2024at 4:00 P.M. at the Corporate Office situated at 207, Saket Nagar, Near Saket Club Indore (M.P.) 452018

Syncom Formulation (India) Ltd.

27 Jul 2024, 01:57PM

16.96

-0.47%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication regarding transfer of Shares to IEPF

Syncom Formulation (India) Ltd.

25 Jul 2024

16.96

-0.47%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

We are Pleased to Inform you that the Company has Considered and RTA of the Company has issued the Letter of Confirmation

Syncom Formulation (India) Ltd.

25 Jul 2024

16.96

-0.47%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

BSE India

We are Pleased to inform you that the Company has launched a new Product under new sub division named "ICURA"- CRITICAL CARE DIVISION

Syncom Formulation (India) Ltd.

19 Jul 2024

16.96

-0.47%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

In accordance with Regulation 74(5) of the SEBI (DP), Reg 2018 we hereby submit for the quarter ended 30th June, 2024 certificate received from RTA.

Syncom Formulation (India) Ltd.

17 Jul 2024

16.96

-0.47%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation regarding issuance of duplicate share / letter of confirmation under Reg 39(3) of SEBI LODR, 2015

Syncom Formulation (India) Ltd.

13 Jul 2024

16.96

-0.47%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation under Reg 39(3) for issuance of Letter of Confirmation due to issue of duplicate share to legal heir

Syncom Formulation (India) Ltd.

02 Jul 2024

16.96

-0.47%

Corp. Note

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation regarding respect for issuance Letter of Confirmation due to issue of duplicate share under Regulation 39(3) of SEBI LODR, 2015

Syncom Formulation (India) Ltd.

28 Jun 2024, 05:20PM

16.96

-0.47%

Company Update

SYNCOM FORMULATIONS (INDIA) LTD.-$ - 524470 - Announcement Pursuant To Regulation 30 Read With Schedule III …

BSE India

Intimation for payment of fine due to waiver rejection for non compliance of Reg 21 (2) of SEBI LODR

Is Syncom Formulation (India) Ltd. worth buying?

867 Votes:

Buy 84.08%

Sell 8.19%

Hold 7.73%